Rituximab in Membranous Nephropathy: Is It a First-Line Treatment?

被引：8

作者：

Appel, Gerald B. ^{[1
]}

机构：

[1] Columbia Univ, Med Ctr, Columbia Univ Coll Phys & Surg, Dept Med,Div Nephrol, New York, NY 10032 USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 23卷 / 08期

关键词：

THERAPY; ANTIGEN;

D O I：

10.1681/ASN.2012060602

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1280 / 1282

页数：3

共 18 条

[1]

[Anonymous], 2012, Kidney Int Suppl (2011), V2, P186

[2] Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy [J].

Beck, Laurence H., Jr. ;

Fervenza, Fernando C. ;

Beck, David M. ;

Bonegio, Ramon G. B. ;

Malik, Fahim A. ;

Erickson, Stephen B. ;

Cosio, Fernando G. ;

Cattran, Daniel C. ;

Salant, David J. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (08) :1543-1550

[3] M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy. [J].

Beck, Laurence H., Jr. ;

Bonegio, Ramon G. B. ;

Lambeau, Gerard ;

Beck, David M. ;

Powell, David W. ;

Cummins, Timothy D. ;

Klein, Jon B. ;

Salant, David J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (01) :11-21

[4] Rituximab Therapy for Membranous Nephropathy: A Systematic Review [J].

Bomback, Andrew S. ;

Derebail, Vimal K. ;

McGregor, Julie G. ;

Kshirsagar, Abhijit V. ;

Falk, Ronald J. ;

Nachman, Patrick H. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (04) :734-744

[5] Progressive multifocal leukoencephalopathy in rheumatic diseases - Evolving clinical and pathologic patterns of disease [J].

Calabrese, Leonard H. ;

Molloy, Eamonn S. ;

Huang, DeRen ;

Ransohoff, Richard M. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (07) :2116-2128

[6] Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial [J].

Cattran, DC ;

Appel, GB ;

Hebert, LA ;

Hunsicker, LG ;

Pohl, MA ;

Hoy, WE ;

Maxwell, DR ;

Kunis, CL .

KIDNEY INTERNATIONAL, 2001, 59 (04) :1484-1490

[7] Efficacy and Safety of Rituximab Second-Line Therapy for Membranous Nephropathy: A Prospective, Matched-Cohort Study [J].

Cravedi, Paolo ;

Sghirlanzoni, Maria Chiara ;

Marasa, Maddalena ;

Salerno, Alessandra ;

Remuzzi, Giuseppe ;

Ruggenenti, Piero .

AMERICAN JOURNAL OF NEPHROLOGY, 2011, 33 (05) :461-468

[8]

Fervenza FC, 2012, NEPHSAP, V11, P135

[9] Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study [J].

Fervenza, Fernando C. ;

Abraham, Roshini S. ;

Erickson, Stephen B. ;

Irazabal, Maria Valentina ;

Eirin, Alfonso ;

Specks, Ulrich ;

Nachman, Patrick H. ;

Bergstralh, Eric J. ;

Leung, Nelson ;

Cosio, Fernando G. ;

Hogan, Marie C. ;

Dillon, John J. ;

Hickson, LaTonya J. ;

Li, Xujian ;

Cattran, Daniel C. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (12) :2188-2198

[10]

Maloney DG, 2012, NEW ENGL J MED, V366, P2008, DOI 10.1056/NEJMct1114348

← 1 2 →